Free Trial

InterCure (NASDAQ:INCR) Trading Up 3.7% - What's Next?

InterCure logo with Medical background

InterCure Ltd. (NASDAQ:INCR - Get Free Report)'s share price was up 3.7% on Tuesday . The stock traded as high as $1.69 and last traded at $1.69. Approximately 25,814 shares were traded during mid-day trading, an increase of 40% from the average daily volume of 18,439 shares. The stock had previously closed at $1.63.

InterCure Stock Up 1.2 %

The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. The company's 50-day moving average price is $1.48 and its 200-day moving average price is $1.82.

Institutional Trading of InterCure

Hedge funds and other institutional investors have recently modified their holdings of the company. Virtu Financial LLC acquired a new stake in InterCure in the 3rd quarter valued at approximately $43,000. Jane Street Group LLC bought a new position in shares of InterCure during the 3rd quarter worth approximately $49,000. Finally, Renaissance Technologies LLC raised its holdings in shares of InterCure by 30.9% in the second quarter. Renaissance Technologies LLC now owns 45,300 shares of the company's stock valued at $91,000 after purchasing an additional 10,700 shares during the last quarter. Institutional investors and hedge funds own 8.34% of the company's stock.

InterCure Company Profile

(Get Free Report)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.

Read More

Should You Invest $1,000 in InterCure Right Now?

Before you consider InterCure, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InterCure wasn't on the list.

While InterCure currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines